Kahn replaces Gurinder Kalra who resigned effective January 30, 2024 to pursue other interests.
Ocean Biomedical: On March 1, 2024, Appointment Of Jolie Kahn As CFO Was Confirmed - Filing
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.